Brief: Sihuan Pharma Says Products Developed By Unit Approved For Market Launch In Hong Kong
20/10/2026 09:57
BRIEF-Sihuan Pharma Says Products Developed By Unit Approved For Market Launch In Hong Kong Oct 20 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:
PRODUCTS DEVELOPED BY MEIYAN SPACE BIOTECHNOLOGY (JILIN) APPROVED FOR MARKET LAUNCH IN HONG KONG
APPROVED PRODUCTS INCLUDE POLYCAPROLACTONE MICROSPHERE FACIAL FILLER FOR INJECTION
Further company coverage: 0460.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on Sihuan Pharmaceutical Holdings
See all newsBrief: Sihuan Pharma Says Products Developed By Unit Approved For Market Launch In Hong Kong
Brief: Sihuan Pharma's Unit Completes Strategic Equity Investment In Canton Biologics
Sihuan gains as Dongyan Skin Booster's new specifications approved for launch
Brief: Sihuan Pharma Says New Specifications Of Dongyan Skin Booster Approved For Launch By NMPA
Sihuan Pharmaceutical H1 profit jumps on medical aesthetics unit strength